Puma BioTech

PBYI

11.1800.71% ( -0.080 )

Trading: Oct 23, 12:20:51 (EDT)

Current ValuationThe current P/E ratio is 21.75, above the reasonable range, cheaper than 6.51% of the time in the past 3 years, and the industry ranks 43/605, the industry Median -1.91.

21.75xP/E

Stock price$11.26Earnings per share$0.52

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

021426384

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
AMGNUSAmgen	27.66x	10.77%	$241.81B
REGNUSRegeneron Pharma	19.48x	12.93%	$84.33B
ARGXUSArgenx	29.18x	43.98%	$54.77B
UTHRUSUnited Therap	19.13x	4.79%	$25.08B
EXELUSExelixis	18.80x	17.02%	$16.18B
ASNDUSAscendis Pharmac	18.59x	470.41%	$15.98B
NBIXUSNeurocrine Biosciences	20.65x	52.50%	$14.57B
TGTXUSTG Therap	18.43x	64.59%	$8.14B
PBYIUSPuma BioTech	21.75x	37.70%	$581.24M
KMDAUSKamada	20.05x	36.43%	$446.10M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.